Business Description
CQ Pharmaceutical Holding Co Ltd
NAICS : 325311
SIC : 2873
ISIN : CNE0000010K0
Share Class Description:
SZSE:000950: Class ACompare
Compare
Traded in other countries / regions
000950.China IPO Date
1999-09-16Description
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.18 | |||||
| Debt-to-Equity | 1.87 | |||||
| Debt-to-EBITDA | 9.81 | |||||
| Interest Coverage | 1.8 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.87 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.2 | |||||
| 3-Year EBITDA Growth Rate | 8.3 | |||||
| 3-Year EPS without NRI Growth Rate | -10.9 | |||||
| 3-Year FCF Growth Rate | 1.6 | |||||
| 3-Year Book Growth Rate | 8.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.5 | |||||
| 9-Day RSI | 66.38 | |||||
| 14-Day RSI | 64.67 | |||||
| 6-1 Month Momentum % | -0.19 | |||||
| 12-1 Month Momentum % | -29.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 1.12 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 39.16 | |||||
| Days Sales Outstanding | 158.01 | |||||
| Days Payable | 82.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.05 | |||||
| Dividend Payout Ratio | 0.11 | |||||
| 3-Year Dividend Growth Rate | 6.3 | |||||
| Forward Dividend Yield % | 1.05 | |||||
| 5-Year Yield-on-Cost % | 1.05 | |||||
| Shareholder Yield % | -7.24 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7.74 | |||||
| Operating Margin % | 2.85 | |||||
| Net Margin % | 0.74 | |||||
| FCF Margin % | 0.26 | |||||
| ROE % | 5.33 | |||||
| ROA % | 0.93 | |||||
| ROIC % | 5.24 | |||||
| ROC (Joel Greenblatt) % | 10.14 | |||||
| ROCE % | 11.03 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.59 | |||||
| PE Ratio without NRI | 10.25 | |||||
| Shiller PE Ratio | 26.86 | |||||
| Price-to-Owner-Earnings | 42.09 | |||||
| PEG Ratio | 0.49 | |||||
| PS Ratio | 0.12 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 1.03 | |||||
| Price-to-Free-Cash-Flow | 31.16 | |||||
| Price-to-Operating-Cash-Flow | 17.47 | |||||
| EV-to-EBIT | 11.4 | |||||
| EV-to-EBITDA | 11.4 | |||||
| EV-to-Revenue | 0.31 | |||||
| EV-to-FCF | 118.69 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.63 | |||||
| Price-to-Graham-Number | 0.69 | |||||
| Price-to-Net-Current-Asset-Value | 4.18 | |||||
| Earnings Yield (Greenblatt) % | 8.77 | |||||
| FCF Yield % | 2.13 | |||||
| Forward Rate of Return (Yacktman) % | 9.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CQ Pharmaceutical Holding Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 80,123.113 | ||
| EPS (TTM) (Â¥) | 0.34 | ||
| Beta | 0.88 | ||
| Volatility % | 25.69 | ||
| 14-Day RSI | 64.67 | ||
| 14-Day ATR (Â¥) | 0.136793 | ||
| 20-Day SMA (Â¥) | 5.4195 | ||
| 12-1 Month Momentum % | -29.55 | ||
| 52-Week Range (Â¥) | 4.28 - 7.93 | ||
| Shares Outstanding (Mil) | 1,728.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CQ Pharmaceutical Holding Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CQ Pharmaceutical Holding Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
CQ Pharmaceutical Holding Co Ltd Frequently Asked Questions
What is CQ Pharmaceutical Holding Co Ltd(SZSE:000950)'s stock price today?
The current price of SZSE:000950 is ¥5.64. The 52 week high of SZSE:000950 is ¥7.93 and 52 week low is ¥4.28.
When is next earnings date of CQ Pharmaceutical Holding Co Ltd(SZSE:000950)?
The next earnings date of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) is .
Does CQ Pharmaceutical Holding Co Ltd(SZSE:000950) pay dividends? If so, how much?
The Dividend Yield %  of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) is 1.05% (As of Today), Highest Dividend Payout Ratio of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) was 0.18. The lowest was 0.08. And the median was 0.12. The  Forward Dividend Yield % of CQ Pharmaceutical Holding Co Ltd(SZSE:000950) is 1.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers